Keyphrases
Cell-based
100%
Stem Cell-derived
100%
Canavan Disease
100%
Induced Pluripotent Stem Cells (iPSCs)
100%
Aspartoacylase
85%
Cell Therapy
42%
Genetic Engineering
28%
N-acetylaspartate
28%
Neural Stem Cells
28%
Oligodendrocyte Precursor Cells
28%
Treatment Options
14%
Mouse Model
14%
Pathological Features
14%
Genetic Disease
14%
Prolonged Survival
14%
Transplantation
14%
Demyelination
14%
Myelination
14%
Vacuolation
14%
Motor Deficits
14%
Spongy Degeneration
14%
Leukodystrophy
14%
Cellular Products
14%
Lentiviral Transduction
14%
TALEN
14%
Cell Progenitors
14%
Human-induced
14%
Neuroscience
Stem Cell
100%
Cell Therapy
100%
Canavan Disease
100%
Aspartoacylase
85%
Aspartic Acid
28%
Neural Stem Cell
28%
Progenitor Cell
28%
Oligodendrocyte Progenitor
28%
Myelinogenesis
14%
Leukodystrophy
14%
Genetic Engineering
14%
Biochemistry, Genetics and Molecular Biology
Canavan Disease
100%
Human Induced Pluripotent Stem Cell
100%
Aspartoacylase
85%
Progenitor Cell
57%
Induced Pluripotent Stem Cell
42%
Oligodendrocyte Progenitor
28%
Aspartic Acid
28%
Mouse Model
14%
Genetic Disorder
14%
Motor Performance
14%
Myelination
14%
Genetic Engineering
14%
Transcription Activator-Like Effector Nuclease
14%
Deficiency
14%